ENT BIOTECH SOLUTIONS, INC. — Form D/A
ENT BIOTECH SOLUTIONS, INC. of GROSSE POINTE FARMS, MI, a company, filed a Form D amendment with the SEC on 2016-04-25. The offering totals $1.8M, of which $1.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2016-04-25
- Form: D/A
- Accession: 0001613649-16-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $1.8M
- Amount sold: $1.1M
- Remaining: $650K
- Minimum investment: $12K
- Investors: 17
- Date of first sale: 2015-03-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-236324
Issuer
- Name: ENT BIOTECH SOLUTIONS, INC.
- CIK: 0001613649
- Entity type: Corporation
- Jurisdiction: MICHIGAN
- Incorporated: 2011
- Address: 75 LEWISTON ROAD, GROSSE POINTE FARMS, MI, 48236
- Phone: 313-590-1878
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Jack Barthell Ball | Director | Detroit, MI |
| Jeffery Barthell Brinza | Director | Detroit, MI |
| Andrea Roumell Dickson | Director | Grosse Pointe Farms, MI |
| C. Barthell Dickson | Director | Grosse Pointe Farms, MI |
| Gretchen Barthell Knoell | Director | Detroit, MI |
| Jeffery Barthell Brinza | Executive Officer | Detroit, MI |
| Andrea Roumell Dickson | Executive Officer | Grosse Pointe Farms, MI |
| Olivier Barthell Lecerf | Executive Officer | Detroit, MI |
| Andrea Roumell Dickson | Promoter | Grosse Pointe Farms, MI |
| C. Barthell Dickson | Promoter | Grosse Pointe Farms, MI |
Other filings by this issuer (2)
More